{"id":"https://openalex.org/W2237516387","doi":"https://doi.org/10.1007/s11095-015-1848-2","title":"A Strategy for Co-former Selection to Design Stable Co-amorphous Formations Based on Physicochemical Properties of Non-steroidal Inflammatory Drugs","display_name":"A Strategy for Co-former Selection to Design Stable Co-amorphous Formations Based on Physicochemical Properties of Non-steroidal Inflammatory Drugs","publication_year":2015,"publication_date":"2015-12-23","ids":{"openalex":"https://openalex.org/W2237516387","doi":"https://doi.org/10.1007/s11095-015-1848-2","mag":"2237516387","pmid":"https://pubmed.ncbi.nlm.nih.gov/26700604"},"language":"en","primary_location":{"id":"doi:10.1007/s11095-015-1848-2","doi":"https://doi.org/10.1007/s11095-015-1848-2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11095-015-1848-2","pdf_url":null,"source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074614484","display_name":"Hiroshi Ueda","orcid":"https://orcid.org/0000-0003-3061-2596","observed_orcids":["https://orcid.org/0000-0003-3061-2596"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]},{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hiroshi Ueda","raw_affiliation_strings":["Laboratory of Formulation Design and Pharmaceutical Technology, Osaka University of Pharmaceutical Sciences, 4-20-1, Nasahara, Takatsuki-shi, Osaka, 569-1094, Japan. hiroshi.ueda@shionogi.co.jp","Physicochemical and Preformulation, Applied Chemistry and Analysis, Research Laboratory for Development, Shionogi & Co., Ltd, 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan. hiroshi.ueda@shionogi.co.jp","Physicochemical and Preformulation, Applied Chemistry and Analysis, Research Laboratory for Development, Shionogi & Co., Ltd, 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Formulation Design and Pharmaceutical Technology, Osaka University of Pharmaceutical Sciences, 4-20-1, Nasahara, Takatsuki-shi, Osaka, 569-1094, Japan. hiroshi.ueda@shionogi.co.jp","institution_ids":["https://openalex.org/I90237989"]},{"raw_affiliation_string":"Physicochemical and Preformulation, Applied Chemistry and Analysis, Research Laboratory for Development, Shionogi & Co., Ltd, 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan. hiroshi.ueda@shionogi.co.jp","institution_ids":["https://openalex.org/I4210118477"]},{"raw_affiliation_string":"Physicochemical and Preformulation, Applied Chemistry and Analysis, Research Laboratory for Development, Shionogi & Co., Ltd, 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089946650","display_name":"Noriyuki Muranushi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriyuki Muranushi","raw_affiliation_strings":["New Technology Department, Formulation Development Center, CMC Development Laboratories, Shionogi & Co., Ltd., 2-1-3, Kuise-Terajima, Amagasaki-shi, Hyogo, 660-0813, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Technology Department, Formulation Development Center, CMC Development Laboratories, Shionogi & Co., Ltd., 2-1-3, Kuise-Terajima, Amagasaki-shi, Hyogo, 660-0813, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001200967","display_name":"Satoshi Sakuma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoshi Sakuma","raw_affiliation_strings":["New Technology Department, Formulation Development Center, CMC Development Laboratories, Shionogi & Co., Ltd., 2-1-3, Kuise-Terajima, Amagasaki-shi, Hyogo, 660-0813, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Technology Department, Formulation Development Center, CMC Development Laboratories, Shionogi & Co., Ltd., 2-1-3, Kuise-Terajima, Amagasaki-shi, Hyogo, 660-0813, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031889047","display_name":"Yasuo Ida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuo Ida","raw_affiliation_strings":["Physicochemical and Preformulation, Applied Chemistry and Analysis, Research Laboratory for Development, Shionogi & Co., Ltd, 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physicochemical and Preformulation, Applied Chemistry and Analysis, Research Laboratory for Development, Shionogi & Co., Ltd, 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065802402","display_name":"Takeshi Endoh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeshi Endoh","raw_affiliation_strings":["Physicochemical and Preformulation, Applied Chemistry and Analysis, Research Laboratory for Development, Shionogi & Co., Ltd, 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physicochemical and Preformulation, Applied Chemistry and Analysis, Research Laboratory for Development, Shionogi & Co., Ltd, 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052577338","display_name":"Kazunori Kadota","orcid":"https://orcid.org/0000-0002-3370-6662","observed_orcids":["https://orcid.org/0000-0002-3370-6662"]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazunori Kadota","raw_affiliation_strings":["Laboratory of Formulation Design and Pharmaceutical Technology, Osaka University of Pharmaceutical Sciences, 4-20-1, Nasahara, Takatsuki-shi, Osaka, 569-1094, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Formulation Design and Pharmaceutical Technology, Osaka University of Pharmaceutical Sciences, 4-20-1, Nasahara, Takatsuki-shi, Osaka, 569-1094, Japan","institution_ids":["https://openalex.org/I90237989"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080893014","display_name":"Yuichi Tozuka","orcid":"https://orcid.org/0000-0002-4091-4451","observed_orcids":["https://orcid.org/0000-0002-4091-4451"]},"institutions":[{"id":"https://openalex.org/I90237989","display_name":"Osaka University of Pharmaceutical Sciences","ror":"https://ror.org/029yaft79","country_code":"JP","type":"education","lineage":["https://openalex.org/I205143321","https://openalex.org/I90237989"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuichi Tozuka","raw_affiliation_strings":["Laboratory of Formulation Design and Pharmaceutical Technology, Osaka University of Pharmaceutical Sciences, 4-20-1, Nasahara, Takatsuki-shi, Osaka, 569-1094, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Formulation Design and Pharmaceutical Technology, Osaka University of Pharmaceutical Sciences, 4-20-1, Nasahara, Takatsuki-shi, Osaka, 569-1094, Japan","institution_ids":["https://openalex.org/I90237989"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5074614484"],"corresponding_institution_ids":["https://openalex.org/I4210118477","https://openalex.org/I90237989"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":2.1607,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.87876394,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"33","issue":"4","first_page":"1018","last_page":"1029"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10474","display_name":"Material Dynamics and Properties","score":0.36250001192092896,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10474","display_name":"Material Dynamics and Properties","score":0.36250001192092896,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.26660001277923584,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10633","display_name":"Metallic Glasses and Amorphous Alloys","score":0.1453000009059906,"subfield":{"id":"https://openalex.org/subfields/2506","display_name":"Metals and Alloys"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9700000286102295},{"id":"https://openalex.org/keywords/naproxen","display_name":"naproxen","score":0.9710000157356262},{"id":"https://openalex.org/keywords/crystallization-inhibition","display_name":"crystallization suppression","score":0.8980000019073486},{"id":"https://openalex.org/keywords/glass-transition-temperature","display_name":"glass transition temperature","score":0.8019999861717224},{"id":"https://openalex.org/keywords/melting-point","display_name":"melting point","score":0.8420000076293945},{"id":"https://openalex.org/keywords/molecular-flexibility","display_name":"molecular flexibility","score":0.8009999990463257},{"id":"https://openalex.org/keywords/isothermal-crystallization","display_name":"isothermal crystallization","score":0.7910000085830688},{"id":"https://openalex.org/keywords/intermolecular-interactions","display_name":"intermolecular interactions","score":0.7549999952316284},{"id":"https://openalex.org/keywords/physicochemical-properties","display_name":"physicochemical properties","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C56052488","wikidata":"https://www.wikidata.org/wiki/Q103382","display_name":"Amorphous solid","level":2,"score":0.8759876489639282},{"id":"https://openalex.org/C203036418","wikidata":"https://www.wikidata.org/wiki/Q284256","display_name":"Crystallization","level":2,"score":0.8418405055999756},{"id":"https://openalex.org/C122865956","wikidata":"https://www.wikidata.org/wiki/Q825643","display_name":"Glass transition","level":3,"score":0.6598926782608032},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.5761125683784485},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.47153741121292114},{"id":"https://openalex.org/C133347239","wikidata":"https://www.wikidata.org/wiki/Q486921","display_name":"Isothermal process","level":2,"score":0.4102437198162079},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.28652316331863403},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.24335679411888123},{"id":"https://openalex.org/C97355855","wikidata":"https://www.wikidata.org/wiki/Q11473","display_name":"Thermodynamics","level":1,"score":0.235835999250412},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.21946439146995544},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.20465871691703796},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.06717196106910706},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002152","descriptor_name":"Calorimetry, Differential Scanning","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003460","descriptor_name":"Crystallization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006358","descriptor_name":"Hot Temperature","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009288","descriptor_name":"Naproxen","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017550","descriptor_name":"Spectroscopy, Fourier Transform Infrared","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044366","descriptor_name":"Transition Temperature","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s11095-015-1848-2","doi":"https://doi.org/10.1007/s11095-015-1848-2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11095-015-1848-2","pdf_url":null,"source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},{"id":"pmid:26700604","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26700604","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W53851219","https://openalex.org/W306852800","https://openalex.org/W1076140267","https://openalex.org/W1498305210","https://openalex.org/W1541765387","https://openalex.org/W1543696264","https://openalex.org/W1969111327","https://openalex.org/W1972974331","https://openalex.org/W1977645028","https://openalex.org/W1979152061","https://openalex.org/W1981344651","https://openalex.org/W1984668363","https://openalex.org/W1987012133","https://openalex.org/W1989461604","https://openalex.org/W1992478909","https://openalex.org/W1994893251","https://openalex.org/W2013133034","https://openalex.org/W2013251375","https://openalex.org/W2016908216","https://openalex.org/W2018312534","https://openalex.org/W2032268755","https://openalex.org/W2038846446","https://openalex.org/W2042502385","https://openalex.org/W2057638048","https://openalex.org/W2066160097","https://openalex.org/W2071713175","https://openalex.org/W2082844130","https://openalex.org/W2083840929","https://openalex.org/W2085793558","https://openalex.org/W2087444064","https://openalex.org/W2090368114","https://openalex.org/W2091462529","https://openalex.org/W2092097415","https://openalex.org/W2094039623","https://openalex.org/W2133061394","https://openalex.org/W2140380619","https://openalex.org/W2155496577","https://openalex.org/W2155692480","https://openalex.org/W2164583936","https://openalex.org/W2315466603","https://openalex.org/W2318848886","https://openalex.org/W2322599725"],"related_works":["https://openalex.org/W2531621699","https://openalex.org/W3157196432","https://openalex.org/W2911120881","https://openalex.org/W2904204419","https://openalex.org/W2604914067","https://openalex.org/W2990034338","https://openalex.org/W7222316647","https://openalex.org/W2315466603","https://openalex.org/W3043302047","https://openalex.org/W2509155808"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":6}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}